Republican SEC Commissioner Mark Uyeda suggests pausing new enforcement actions against firms that have failed to register ...

The United States Securities and Exchange Commission maintains regulatory pressure on the cryptocurrency exchange Kraken in ...

Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination product candidate for the treatment of Parkinson’s Disease (“PD”) and Hepion ...

The Securities and Exchange Commission’s Division of Examinations ... should pay particular attention to the risks posed by conflicts of interest. Dual registration may create an incentive for ...

On October 21, 2024, the Division of Examinations (“EXAMS” or the “Division”) of the U.S. Securities and Exchange Commission ...

The SEC failed to adequately plead claims that the Binance.US cryptocurrency exchange violated securities laws by failing to ...

The firm filed a Form S-1 registration statement with the Securities and Exchange Commission (SEC) on Friday. The proposed ...

"We are pleased the SEC has declared effective the registration statement and that the proxy statement has been mailed, marking a significant milestone in our proposed business combination with Roth ...

has filed a registration statement on Form S-4 with the Securities and Exchange Commission (“SEC”) relating to the previously announced proposed merger ( the “Merger”) with Verde Bioresins, Inc.

Kraken’s attorney, Michael O’Connor, criticized the SEC’s move on Wednesday, calling it an ‘Election Day gambit.’ ...

NORMAN — OU football annihilated Maine 59-14 Saturday, but it's Maine. The Sooners' offense finished with 665 yards. Running ...

Pharma Two B and Hepion Pharmaceuticals (HEPA) announced that the U.S. Securities and Exchange Commission has declared effective the ...